PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

CMA accuses four pharmas of anticompetitive behaviour

Four pharma companies stand accused in the UK of colluding to artificially inflate the price of prescription-only, anti-nausea and dizziness drug prochlorperazine...
Continue Reading →
News

Trump to unveil executive order to force drug cost disclosure: WSJ

President Donald Trump is expected to sign an executive order that would mandate the disclosure of costs in the healthcare industry, including drug prices, The Wall...
Continue Reading →
News

Novartis grabs blockbuster cancer nod for Piqray on double good news day

Novartis' breast cancer drug Piqray has become the first new molecular entity approved under the FDA's Real-Time Oncology Review pilot program. (Novartis) Novart...
Continue Reading →
News

Private payers cover more than 40% of drug costs

Medicare, Medicaid and private payers cover 82% of retail prescription drug spending, according to a new Kaiser Family Foundation (KFF) analysis.Private health in...
Continue Reading →
News

China’s driving sales growth ahead of the U.S. for Big Pharma. But can it last?

Several multinational pharma companies are expecting headwinds in China due to the "4+7" bulk procurement scheme. (SW1994/Pixabay) If you follow Big Pharma compa...
Continue Reading →
News

Emcure injected schizophrenia drug recalled after contamination detected

Emcure Pharmaceuticals, which received a warning letter for a sterile manufacturing plant in 2016, is now having injected drugs recalled over microbial contaminatio...
Continue Reading →
News

Celgene, Lyfebulb put patient spin on MS innovation challenge

Celgene and Lyfebulb's innovation challenge for multiple sclerosis solutions is unique in that the ideas are sourced only from patient entrepreneurs. (Peshkova/iSto...
Continue Reading →
News

B. Braun invests $1B in IV fluid manufacturing to alleviate shortages

B. Braun Medical is investing $1 billion into new and existing intravenous fluid manufacturing facilities to address the IV solution shortage, which was exacerbat...
Continue Reading →
News

ICER seeks to make drug price research more accessible

The Institute for Clinical and Economic Review, a looked-to nonprofit group, plans to develop a subscription service for payers and pharmaceutical companies to more ...
Continue Reading →
News

FDA highlights manufacturing quality efforts after recalls, regulatory criticism

The Food and Drug Administration issued its annual report Monday on the state of pharmaceutical quality, highlighting its inspection efforts and offering geograph...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026